MoneyWorks4Me

Dishman Carbogen Amcis informs about credit rating

22 Dec 2022 Evaluate
Dishman Carbogen Amcis has informed that India Ratings & Research ('Ind-Ra') has affirmed the Company's Rating for long term credit facilities at 'IND A+', for short term credit facilities at 'IND A1+', and assigned Rating for Proposed non-convertible debentures/term loan at 'IND A+’ with a 'Stable' outlook. Since the company did not proceed with the commercial paper instrument as envisaged, based upon company's request, it has withdrawn Rating for this instrument. Details of instrument wise rating are mentioned in the attached file.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..